{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreie63ysbt5r3mmvr76ob7piornazv53ezdl2rksrjtpridzlo3z3ki",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mi3qtd43go32"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihs4yniv5gslv4xxwpwazmdqvpsj3sble4olz6hvbzdguafle3ihy"
    },
    "mimeType": "image/jpeg",
    "size": 123080
  },
  "path": "/pharmalot/2026/03/27/novo-nordisk-boost-consumer-focus-fda-approves-gene-therapy/?utm_campaign=rss",
  "publishedAt": "2026-03-27T13:25:17.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharma",
    "Pharmalot",
    "pharmalittle",
    "STAT+"
  ],
  "textContent": "Novo Nordisk appointed Poul Weihrauch, CEO of the Mars candy company, as board observer as it tries to boost its consumer focus",
  "title": "STAT+: Pharmalittle: We’re reading about Novo Nordisk boosting consumer focus, FDA approving a gene therapy, and more",
  "updatedAt": "2026-03-27T13:27:13.000Z"
}